Vanda Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:VM4 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
14 Nov 24	Sell€24,446	Stephen Mitchell	Individual	5,000	€4.89
29 Jul 24	Sell€12,314	Kevin Moran	Individual	2,251	€5.47
05 Mar 24	Sell€67,523	Gunther Birznieks	Individual	17,411	€3.95
05 Mar 24	Sell€58,334	Kevin Moran	Individual	14,700	€4.12
05 Mar 24	Sell€212,878	Mihael Polymeropoulos	Individual	55,172	€3.91
05 Mar 24	Sell€66,182	Joakim Wijkstrom	Individual	16,727	€4.06
05 Mar 24	Sell€67,462	Timothy Williams	Individual	17,088	€4.06

Insider Trading Volume

Insider Buying: VM4 insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of VM4?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	1,674,896	2.87%
Hedge Funds	4,011,522	6.88%
General Public	11,267,588	19.3%
Institutions	41,354,138	70.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 63.9% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
14.7%	BlackRock, Inc.	8,595,607	€36.6m	5.62%	no data
6.88%	Renaissance Technologies LLC	4,011,522	€17.1m	-2.49%	0.03%
6.23%	The Vanguard Group, Inc.	3,631,289	€15.4m	5.82%	no data
4.04%	Tang Capital Management, LLC	2,353,307	€10.0m	9.29%	0.75%
3.88%	Dimensional Fund Advisors LP	2,261,091	€9.6m	12.3%	no data
3.26%	Acadian Asset Management LLC	1,900,002	€8.1m	-4.14%	0.02%
2.73%	Nantahala Capital Management, LLC	1,593,516	€6.8m	0%	0.52%
2.45%	Jacobs Levy Equity Management Inc	1,430,533	€6.1m	-3.75%	0.02%
2.45%	Geode Capital Management, LLC	1,425,827	€6.1m	7.13%	no data
2.14%	Mihael Polymeropoulos	1,249,230	€5.3m	0%	no data
2%	State Street Global Advisors, Inc.	1,165,182	€5.0m	-3.81%	no data
1.78%	Schroder Investment Management Limited	1,038,020	€4.4m	-10.2%	no data
1.34%	Connor, Clark & Lunn Investment Management Ltd.	780,933	€3.3m	7.66%	0.02%
1.23%	Federated Hermes, Inc.	716,779	€3.0m	0.16%	0.01%
1.1%	PGIM, Inc.	642,580	€2.7m	-0.05%	no data
1.02%	Charles Schwab Investment Management, Inc.	596,210	€2.5m	0%	no data
0.96%	D. E. Shaw & Co., L.P.	559,798	€2.4m	-19.2%	no data
0.94%	Goldman Sachs Asset Management, L.P.	548,494	€2.3m	105%	no data
0.86%	Northern Trust Global Investments	501,159	€2.1m	2.93%	no data
0.72%	Bridgeway Capital Management, LLC	419,487	€1.8m	-35.2%	0.03%
0.71%	Krensavage Asset Management, LLC	414,684	€1.8m	-37.4%	1.03%
0.69%	Millennium Management LLC	399,510	€1.7m	2,360%	no data
0.64%	SEI Investments Management Corporation	372,375	€1.6m	-6.31%	no data
0.57%	Profit Investment Management, LLC	329,822	€1.4m	0%	1.18%
0.55%	SEI Investments Company	319,956	€1.4m	-19%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/02 03:07
End of Day Share Price	2025/01/31 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vanda Pharmaceuticals Inc. is covered by 20 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
null null	Argus Research Company
Olivia Brayer	BofA Global Research
Difei Yang	Brean Capital